What's remarkable is that many common human pathogens, including Staphylococcus and Pseudomonas, will cause intestinal infection and kill the worms.
Moreover, various Gram-positive bacteria including Staphylococcus aureus, Microbacterium barkeri, and Bacillus subtilis could also be efficiently inactivated in the photocatalytic system.
To analyze its clinical potential, the activity of PAF26 has been determined against several microorganisms of clinical relevance including Staphylococcus, Candida, and several dermatophytes.
Several of these molecules exhibit potent antibacterial activities against the tested Gram-positive bacteria, including Staphylococcus aureus, Enterococcus faecalis, and Bacillus subtilis.
This peptide, which was first isolated from the saprophytic fungus Pseudoplectania nigrella, exhibits strong bactericidal activity toward several gram-positive pathogens, including Staphylococcus aureus and Streptococcus pneumoniae.
In the present study, we have synthesized a series of very short arginine, lysine and tryptophan containing lipopeptides and evaluated their antimicrobial activities against a panel of pathogenic microorganisms including Staphylococcus aureus, Escherichia coli, and Candida albicans.
Pathological analysis showed polymicrobial flora including Staphylococcus aureus, Eikenella corrodens, Clostridium clostridiforme, and Prevotella buccae.
Another 12% of cases are reported with staphylococci as the organism isolated, including Staphylococcus aureus and haemolyticus.
The results showed that the microorganism index, including Staphylococcus aureus and E. coli, met the requirements of the national standard.
The inhibition studies were performed against different bacterial species including Staphylococcus aureus, Bacillus cereus, Micrococcus luteus, Escherichia coli, Klebsiella pneumoniae.
More clinically important bacteria were recovered from SPB with sucrose (P less than or equal to 0.001), including Staphylococcus epidermidis, Enterobacteriaceae, and Bacteroidaceae.
